Harjumaa, Estonia

Margus Eek

This inventor holds 1 USPTO granted patent. Top assignees: Cambrex Tallinn as, Tallinn University of Technology. Active years: 2012.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Margus Eek: Innovator in Chemical Synthesis

Introduction

Margus Eek is a notable inventor based in Harjumaa, Estonia. He has made significant contributions to the field of chemical synthesis, particularly in the development of methods for producing homocitric acid gamma-lactone and its corresponding salts. His innovative approach has garnered attention in the scientific community.

Latest Patents

Margus Eek holds 1 patent for his work on "Archiral (2-hydroxy-3-oxo-cyclopent-1-enyl) acetic acid alkyl, alkylphenyl and phenyl esters." This patent describes a simple and efficient method for synthesizing both enantiomers of homocitric acid gamma-lactone. The method involves asymmetric oxidation of esters, followed by basic and acidic hydrolysis, culminating in the acidic lactonization of homocitric acid. The process emphasizes the importance of the esters, conditions, and reagents used in the chemical conversion, leading to an efficient production method.

Career Highlights

Throughout his career, Margus Eek has worked with esteemed institutions such as Tallinn University of Technology and Cambrex Tallinn AS. His experience in these organizations has contributed to his expertise in chemical synthesis and innovation.

Collaborations

Margus has collaborated with several professionals in his field, including Anne Paju and Raissa Jaalaid. These partnerships have likely enhanced his research and development efforts.

Conclusion

Margus Eek is a distinguished inventor whose work in chemical synthesis has led to innovative methods for producing valuable compounds. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…